H-LLLTVLTVV-OH
Ref. 3D-PP43260
| 1mg | 217.00 € | ||
| 10mg | 253.00 € | ||
| 100mg | 455.00 € |
Product Information
- NH2-Leu-Leu-Leu-Thr-Val-Leu-Thr-Val-Val-OH
Peptide H-LLLTVLTVV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LLLTVLTVV-OH include the following: Protection against MUC1 expressing mouse tumours by intra-muscular injection of MUC1 cDNA requires functional CD8+ and CD4+ T cells but does not require the T Plunkett, R Graham, I Correa, R Sewell - journal of cancer, 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.20040 A human cytotoxic T-lymphocyte epitope and its agonist epitope from the nonvariable number of tandem repeat sequence of MUC-1 KY Tsang, C Palena, J Gulley , P Arlen, J Schlom - Clinical cancer research, 2004 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/10/6/2139/185513 Responses of human T cells to peptides flanking the tandem repeat and overlapping the signal sequence of MUC1 I Correa, T Plunkett, J Coleman - journal of cancer, 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.20949 Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers HR Bohnenkamp, J Coleman , JM Burchell - Cellular , 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874904002059 Cross-priming of cyclin B1, MUC-1 and survivin-specific CD8+T cells by dendritic cells loaded with killed allogeneic breast cancer cells H Saito, P Dubsky, C Dantin, OJ Finn - Breast Cancer , 2006 - Springerhttps://link.springer.com/article/10.1186/bcr1621 Auto-reactive T cells revised. Overestimation based on methodology? G Thorlacius-Ussing, JF Sorensen, HH Wandall - Journal of , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022175915000861 Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas G Picco, R Beatson - European journal of , 2014 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201344076 Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed CJ Cohen , N Hoffmann, M Farago, HR Hoogenboom - Cancer research, 2002 - AACRhttps://aacrjournals.org/cancerres/article-abstract/62/20/5835/509304
Chemical properties
Technical inquiry about: 3D-PP43260 H-LLLTVLTVV-OH
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
